Cargando…
Development of Glucose Transporter (GLUT) Inhibitors
The discovery of novel compound classes endowed with biological activity is at the heart of chemical biology and medicinal chemistry research. This enables novel biological insights and inspires new approaches to the treatment of diseases. Cancer cells frequently exhibit altered glycolysis and gluco...
Autores principales: | Reckzeh, Elena S., Waldmann, Herbert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7217229/ https://www.ncbi.nlm.nih.gov/pubmed/32421048 http://dx.doi.org/10.1002/ejoc.201901353 |
Ejemplares similares
-
Small‐Molecule Inhibition of Glucose Transporters GLUT‐1–4
por: Reckzeh, Elena S., et al.
Publicado: (2019) -
Synthesis of Indomorphan Pseudo‐Natural Product Inhibitors of Glucose Transporters GLUT‐1 and ‐3
por: Ceballos, Javier, et al.
Publicado: (2019) -
Expression of the glucose transporters GLUT1, GLUT3, GLUT4 and GLUT12 in human cancer cells
por: Barron, Carly, et al.
Publicado: (2012) -
Chances and risks of sodium-glucose cotransporter 2 inhibitors in solid organ transplantation: A review of literatures
por: Schwarzenbach, Marlene, et al.
Publicado: (2021) -
Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
por: Krzeslak, Anna, et al.
Publicado: (2012)